Genomic Health (FRA:G7H) Total Tax Payable : €0.0 Mil (As of Sep. 2019)

View and export this data going back to . Start your Free Trial

What is Genomic Health Total Tax Payable?

Genomic Health's Total Tax Payable for the quarter that ended in Sep. 2019 was €0.0 Mil.

Genomic Health's annual Total Tax Payable declined from Dec. 2016 (€0.8 Mil) to Dec. 2017 (€0.6 Mil) but then increased from Dec. 2017 (€0.6 Mil) to Dec. 2018 (€1.0 Mil).

Genomic Health Total Tax Payable Historical Data

The historical data trend for Genomic Health's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomic Health Total Tax Payable Chart

Genomic Health Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Total Tax Payable

Get a 7-Day Free Trial

0.16

0.34

0.76

0.63

0.96

Genomic Health Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Total Tax Payable	Get a 7-Day Free Trial															-	0.96	-	-	-

Genomic Health Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Genomic Health Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Genomic Health's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomic Health (FRA:G7H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genomic Health Inc (FRA:G7H) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

301 Penobscot Drive, Redwood City, CA, USA, 94063

Website

http://www.genomichealth.com

Genomic Health Inc provides genomic-based diagnostic tests that focus on the treatment of early-stage cancer. The firm's Oncotype DX tests analyze the expression levels of genes in tumor tissue samples and provide a numeric score that physicians can use to determine the aggressiveness of breast, colon, or prostate cancer. These test results can guide decisions about the use of chemotherapy, radiation, surgery, or other aggressive treatments. The Oncotype DX breast cancer test generates the majority of the firm's revenue, analyzing 21 genes to determine the optimal treatment for stage I, II, or IIa breast cancer. The majority of Genomic Health's sales occur within the United States.

Genomic Health (FRA:G7H) Headlines

No Headlines